H M Ziglam
Overview
Explore the profile of H M Ziglam including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
98
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Choudhry M, Soran H, Ziglam H
QJM
. 2008 Apr;
101(6):445-8.
PMID: 18411220
Background: Clostridium difficile is the most common infectious cause of colitis and has been increasingly diagnosed in hospitalized patients. The number of prescriptions for proton pump inhibitors (PPIs) has also...
2.
Ziglam H, Gelly K, Olver W
Int J Antimicrob Agents
. 2007 Feb;
29(4):430-3.
PMID: 17293091
A nationwide questionnaire-based survey was performed to define the different practices in managing febrile neutropenia in oncology units and the use of antimicrobial chemotherapy prophylaxis. A 69.7% response rate was...
3.
Ziglam H, Morales D, Webb K, Nathwani D
J Antimicrob Chemother
. 2006 Mar;
57(5):963-5.
PMID: 16533829
Background: Prescribing of antibiotics, often in the empirical setting, frequently falls on training-grade or junior doctors, who are often the least experienced in this. Indeed, improving the knowledge base of...
4.
Ziglam H, Gelly K, Olver W
Clin Lab Haematol
. 2005 Nov;
27(6):374-8.
PMID: 16307538
We performed a nationwide survey to define the different practices in managing febrile neutropenia in haematology units. A questionnaire was sent out to a named haematologist in each of 220...
5.
Ziglam H, Elliott I, Wilson V, Hill K, Nathwani D
J Antimicrob Chemother
. 2005 Jun;
56(2):423-6.
PMID: 15946987
Objectives: Linezolid, the first available agent in the new class of oxazolidinone antibiotics, represents a significant advance in the management options available for combating methicillin-resistant Staphylococcus aureus (MRSA) infections. In...
6.
Olver W, Carmichael I, Ziglam H, Morrison D
J Hosp Infect
. 2005 Apr;
60(1):87-8.
PMID: 15823666
No abstract available.
7.
Ziglam H, Daniels I, Finch R
J Chemother
. 2004 Aug;
16(4):357-61.
PMID: 15332711
It has been shown that some antibiotics can modify cytokine production. We have examined the effect of rifampicin on secretion of interleukin-1beta (IL-1beta), IL-6, IL-10, and tumor necrosis factor alpha...
8.
Ziglam H, Finch R
Clin Microbiol Infect
. 2001 Nov;
7 Suppl 4:53-65.
PMID: 11688535
The glycopeptide antibacterial drugs vancomycin and teicoplanin are widely used in hospitals for therapy of severe or multiresistant Gram-positive infections, notably staphylococcal, enterococcal and rarely pneumococcal. Vancomycin has also been...